SXI Life Sciences
7.632,83
PKT
-4,77
PKT
-0,06
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.07.12 | Novartis buy | Deutsche Bank AG | |
| 28.06.12 | Novartis buy | Deutsche Bank AG | |
| 28.06.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 25.06.12 | Novartis neutral | UBS AG | |
| 25.06.12 | Novartis buy | UBS AG | |
| 25.06.12 | Sonova buy | Vontobel Research | |
| 22.06.12 | Novartis outperform | Credit Suisse Group | |
| 22.06.12 | Lonza outperform | Cheuvreux SA | |
| 19.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 19.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 14.06.12 | Straumann underperform | Cheuvreux SA | |
| 13.06.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 12.06.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 12.06.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 11.06.12 | Novartis hold | Vontobel Research | |
| 08.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 08.06.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 05.06.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 05.06.12 | Novartis hold | Vontobel Research | |
| 04.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 04.06.12 | Novartis neutral | Citigroup Corp. | |
| 04.06.12 | Straumann hold | Vontobel Research | |
| 04.06.12 | Novartis hold | Vontobel Research | |
| 01.06.12 | Lonza hold | Vontobel Research | |
| 31.05.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 31.05.12 | Novartis buy | Deutsche Bank AG | |
| 30.05.12 | Novartis outperform | Credit Suisse Group | |
| 29.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 29.05.12 | Novartis buy | UBS AG | |
| 29.05.12 | Novartis buy | UBS AG | |
| 25.05.12 | Newron PharmaceuticalsAz. kaufen | Hanseatischer Börsendienst | |
| 23.05.12 | Sonova buy | Vontobel Research | |
| 23.05.12 | Novartis hold | Vontobel Research | |
| 22.05.12 | Sonova neutral | Sarasin Research | |
| 22.05.12 | Sonova buy | Vontobel Research | |
| 21.05.12 | Straumann hold | Vontobel Research | |
| 18.05.12 | Sonova equal-weight | Morgan Stanley | |
| 18.05.12 | Novartis hold | Vontobel Research | |
| 17.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 16.05.12 | Newron PharmaceuticalsAz. buy | Vontobel Research |